Significant Ownership of Jorey Chernett
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Jorey Chernett focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Jorey Chernett - Jorey Chernett
- Manager location
- Bloomfield Hills, MI
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Jorey Chernett with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Jorey Chernett
Significant Ownership of Jorey Chernett
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| KZIA | KAZIA THERAPEUTICS LTD | American Depositary Shares | 18% | 2,114,649 | +33% | Chernett Jorey | 26 May 2026 | ||
| STIM | Neuronetics, Inc. | Common Stock, $0.01 par value | 15% | $18,954,289 | +$62,650 | 10,588,988 | +0.33% | Chernett Jorey | 03 Aug 2026 |
| AIRS | Airsculpt Technologies, Inc. | Common Stock, $0.001 Par Value Per Share | 11% | $13,156,713 | +$1,213,955 | 6,781,811 | +10% | Chernett Jorey | 02 Mar 2026 |
| TOI | Oncology Institute, Inc. | Common Stock, $0.0001 Par Value Per Share | 10% | $27,110,730 | 10,115,944 | Chernett Jorey | 13 Mar 2026 | ||
| XGN | EXAGEN INC. | Common Stock, $0.001 Par Value Per Share | 9.9% | $6,469,255 | +$3,169,001 | 2,413,901 | +96% | Chernett Jorey | 31 Mar 2026 |
| AEON | AEON Biopharma, Inc. | Common | 9.9% | $564,250 | 1,128,500 | Chernett Jorey | 27 May 2025 | ||
| Neuronetics, Inc. | Common | 9.9% | 6,827,031 | +55% | Chernett Jorey | 30 Jan 2026 | |||
| OKYO | OKYO Pharma Ltd | Common | 9.5% | $11,824,823 | +$2,541,903 | 3,802,194 | +27% | Chernett Jorey | 31 Dec 2025 |
| FEMY | FEMASYS INC | Common | 9.3% | $2,930,561 | +$1,361,799 | 3,034,335 | +87% | Chernett Jorey | 30 Jun 2025 |
| SMHI | SEACOR Marine Holdings Inc. | Common Stock, $0.01 par value | 7.2% | $14,310,178 | +$514,500 | 1,946,963 | +3.7% | Chernett Jorey | 22 Jun 2026 |
| TRAW | Traws Pharma, Inc. | Common | 6.8% | $668,220 | 543,268 | Chernett Jorey | 14 Jan 2026 | ||
| MOB | Mobilicom Ltd | Ordinary Shares, no par value per share | 6.4% | $4,171,506 | 813,159 | Chernett Jorey | 28 Apr 2026 | ||
| TLSA | Tiziana Life Sciences Ltd | Common | 5.4% | 6,476,471 | +8.8% | Chernett Jorey | 30 Sep 2025 | ||
| DFPH | Oncology Institute, Inc. | Common | 5.2% | 5,114,944 | Chernett Jorey | 14 Jan 2026 | |||
| ADAG | Adagene Inc. | Ordinary shares, par value US$0.0001 per share | 5.1% | $7,764,445 | 2,389,060 | Chernett Jorey | 16 Mar 2026 | ||
| WW | WW INTERNATIONAL, INC. | Common stock, no par value | 5.1% | $5,783,858 | 507,356 | Chernett Jorey | 14 May 2026 | ||
| LCTX | Lineage Cell Therapeutics, Inc. | Common | 5% | $13,848,454 | 11,445,003 | Chernett Jorey | 22 Sep 2025 | ||
| IOBTQ | IO Biotech, Inc. | Common Stock, $0.001 Par Value Per Share | 0% | $0 | -$45,435 | 0 | -100% | Chernett Jorey | 31 Mar 2026 |
| CALC | CalciMedica, Inc. | Common Stock, $0.0001 Par Value Per Share | 0% | $0 | -$658,211 | 0 | -100% | Chernett Jorey | 31 Mar 2026 |
Schedules 13D/G Reported by Jorey Chernett:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.